These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9679608

  • 1. [Acarbose, an unduly neglected antidiabetic drug].
    Iványi J, Gyimesi A.
    Orv Hetil; 1996 Dec 08; 137(49):2737-41. PubMed ID: 9679608
    [Abstract] [Full Text] [Related]

  • 2. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov 08; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
    Domke A, Willms B.
    Med Klin (Munich); 1994 Apr 15; 89(4):187-92. PubMed ID: 8015532
    [Abstract] [Full Text] [Related]

  • 4. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H, Höxter G.
    Fortschr Med; 1994 Nov 20; 112(32):467-70. PubMed ID: 7821886
    [Abstract] [Full Text] [Related]

  • 5. Modification in sucrose tolerance test with acarbose, guargum and their combination in patients with non-insulin dependent diabetes.
    Shah PK, Lakhotia M, Purohit A, Jain SK, Gupta SK, Bhandari P.
    J Assoc Physicians India; 1993 Nov 20; 41(11):703-5. PubMed ID: 8005921
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ.
    Diabetes Metab; 1998 Sep 20; 24(4):311-20. PubMed ID: 9805641
    [Abstract] [Full Text] [Related]

  • 7. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M, Mujica V, Muñoz S, Durruty P, Larenas G, López MI, Kuzmanic A, Pérez J, Flaskamp R, Cumsille F.
    Rev Med Chil; 1997 Aug 20; 125(8):856-62. PubMed ID: 9580485
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of acarbose as monotherapy in NIDDM patients.
    Deerochanawong C, Serirat S, Kornthong P.
    J Med Assoc Thai; 1996 Feb 20; 79(2):69-75. PubMed ID: 8868016
    [Abstract] [Full Text] [Related]

  • 9. The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose.
    Lecavalier L, Hamet P, Chiasson JL.
    Diabete Metab; 1986 Jun 20; 12(3):156-61. PubMed ID: 3525270
    [Abstract] [Full Text] [Related]

  • 10. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
    Graham JP, Stam D.
    Pharm Pract Manag Q; 1997 Oct 20; 17(3):1-9. PubMed ID: 10173306
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
    Soonthornpun S, Rattarasarn C, Thamprasit A, Leetanaporn K.
    J Med Assoc Thai; 1998 Mar 20; 81(3):195-200. PubMed ID: 9623011
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR.
    Clin Invest Med; 1995 Aug 20; 18(4):312-7. PubMed ID: 8549018
    [Abstract] [Full Text] [Related]

  • 14. The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study.
    Spengler M, Cagatay M.
    Clin Invest Med; 1995 Aug 20; 18(4):325-31. PubMed ID: 8549020
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study.
    Hoffmann J, Spengler M.
    Am J Med; 1997 Dec 20; 103(6):483-90. PubMed ID: 9428831
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J, Soszyński P.
    Przegl Lek; 1999 Dec 20; 56(5):335-41. PubMed ID: 10554569
    [Abstract] [Full Text] [Related]

  • 17. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL.
    Diabet Med; 1996 Dec 20; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
    [Abstract] [Full Text] [Related]

  • 18. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage.
    Frati Munari AC, Benítez Pinto W, Raúl Ariza Andraca C, Casarrubias M.
    Arch Med Res; 1998 Dec 20; 29(2):137-41. PubMed ID: 9650328
    [Abstract] [Full Text] [Related]

  • 19. Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus.
    Dimitriadis G, Karaiskos C, Raptis S.
    Horm Metab Res; 1986 Apr 20; 18(4):253-5. PubMed ID: 3519413
    [Abstract] [Full Text] [Related]

  • 20. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C, Haupt E, Walter T, Werner J.
    Diabetes Nutr Metab; 2002 Jun 20; 15(3):143-51. PubMed ID: 12173728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.